Susquehanna Raises Estimates on Allergen (AGN) as Botox Sales Are on The Rise
Tweet Send to a Friend
Susquehanna is maintaining their Positive rating on shares of Allergen (NYSE: AGN) as the firm suspects that the company will ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
